Form: S-8

Securities to be offered to employees in employee benefit plans

March 23, 2026

Documents

0001382101N/AEX-FILING FEES00013821012026-03-232026-03-23000138210112026-03-232026-03-23xbrli:purexbrli:sharesiso4217:USD

 

Exhibit 107.1

Calculation of Filing Fee Tables

Form S-8 (Form Type)

Sutro Biopharma, Inc.

(Exact Name of Registrant as Specified in its Charter)

 

Newly Registered Securities

 

Security Type

Security Class Title

Fee Calculation Rule

Amount Registered

Proposed Maximum Offering Price Per Unit

Maximum Aggregate Offering Price

Fee Rate

Amount of Registration Fee

1

Equity

Common stock, par value $0.001 per share

Rule 457(c) and Rule 457(h)

429,215

$21.42

$9,193,785

0.0001381

$1,270

 

 

Total Offering Amounts:

 

$9,193,785

N/A

$1,270

 

 

Total Fee Offsets:

 

 

 

$0

 

 

Net Fee Due:

 

 

 

1,270

 

Offering Note

 

 

 

Pursuant to Rule 416(a) promulgated under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement shall also cover any additional shares of common stock, par value $0.001 per share (“Common Stock”), that become issuable under the plans set forth herein by reason of any stock dividend, stock split, recapitalization, or other similar transaction effected that results in an increase to the number of outstanding shares of Sutro Biopharma, Inc.’s (the “Registrant”) Common Stock.

1

 

(1) Represents additional shares of Common Stock to be registered and available for grant under the Registrant’s 2018 Equity Incentive Plan (the “2018 EIP”) resulting from the annual 5% automatic increase in the number of authorized Shares available for issuance under the 2018 EIP.

 

(2) Estimated in accordance with Rules 457(c) and 457(h) of the Securities Act solely for the purpose of calculating the registration fee. The proposed maximum offering price per Share of $21.42 was computed by averaging the high and low prices of a share of Registrant’s common stock as reported on The Nasdaq Global Market on March 19, 2026.